BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21293004)

  • 1. Effect of the oxLDL binding protein Fc-CD68 on plaque extension and vulnerability in atherosclerosis.
    Zeibig S; Li Z; Wagner S; Holthoff HP; Ungerer M; Bültmann A; Uhland K; Vogelmann J; Simmet T; Gawaz M; Münch G
    Circ Res; 2011 Mar; 108(6):695-703. PubMed ID: 21293004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Scavenger Receptor CD68 Regulates Platelet Mediated Oxidized Low-Density Lipoprotein (oxLDL) Deposition in Atherosclerotic Vessels at an Early Stage of Atherosclerosis in LDLR
    Zeibig S; Büttcher M; Goebel S; Pauli J; Hunger A; Ungerer M; Gawaz M; Münch G
    Cell Physiol Biochem; 2019; 52(4):681-695. PubMed ID: 30921507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of foam cell formation using a soluble CD68-Fc fusion protein.
    Daub K; Siegel-Axel D; Schönberger T; Leder C; Seizer P; Müller K; Schaller M; Penz S; Menzel D; Büchele B; Bültmann A; Münch G; Lindemann S; Simmet T; Gawaz M
    J Mol Med (Berl); 2010 Sep; 88(9):909-20. PubMed ID: 20454888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression.
    Tang FT; Cao Y; Wang TQ; Wang LJ; Guo J; Zhou XS; Xu SW; Liu WH; Liu PQ; Huang HQ
    Eur J Pharmacol; 2011 Jan; 650(1):275-84. PubMed ID: 20854809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
    Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
    Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of everolimus on pre-existing atherosclerosis in LDL-receptor deficient mice.
    Beutner F; Brendel D; Teupser D; Sass K; Baber R; Mueller M; Ceglarek U; Thiery J
    Atherosclerosis; 2012 Jun; 222(2):337-43. PubMed ID: 22446027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet.
    Mehta JL; Sanada N; Hu CP; Chen J; Dandapat A; Sugawara F; Satoh H; Inoue K; Kawase Y; Jishage K; Suzuki H; Takeya M; Schnackenberg L; Beger R; Hermonat PL; Thomas M; Sawamura T
    Circ Res; 2007 Jun; 100(11):1634-42. PubMed ID: 17478727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perilipin1 deficiency in whole body or bone marrow-derived cells attenuates lesions in atherosclerosis-prone mice.
    Zhao X; Gao M; He J; Zou L; Lyu Y; Zhang L; Geng B; Liu G; Xu G
    PLoS One; 2015; 10(4):e0123738. PubMed ID: 25855981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A functional role for inducible costimulator (ICOS) in atherosclerosis.
    Afek A; Harats D; Roth A; Keren G; George J
    Atherosclerosis; 2005 Nov; 183(1):57-63. PubMed ID: 15941568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
    Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
    Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
    Rozenberg I; Sluka SH; Rohrer L; Hofmann J; Becher B; Akhmedov A; Soliz J; Mocharla P; Borén J; Johansen P; Steffel J; Watanabe T; Lüscher TF; Tanner FC
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):923-30. PubMed ID: 20203300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.
    van Puijvelde GH; Hauer AD; de Vos P; van den Heuvel R; van Herwijnen MJ; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
    Circulation; 2006 Oct; 114(18):1968-76. PubMed ID: 17060383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive assessment of atherosclerotic plaque progression in ApoE-/- mice using susceptibility gradient mapping.
    Makowski MR; Varma G; Wiethoff AJ; Smith A; Mattock K; Jansen CH; Warley A; Taupitz M; Schaeffter T; Botnar RM
    Circ Cardiovasc Imaging; 2011 May; 4(3):295-303. PubMed ID: 21422166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin suppresses apoptosis in vulnerable atherosclerotic plaques through regulating the expression of p(53), Bcl-2 and Bcl-xL.
    Qin W; Lu Y; Zhan C; Shen T; Dou L; Man Y; Wang S; Xiao C; Bian Y; Li J
    Cardiovasc Drugs Ther; 2012 Feb; 26(1):23-30. PubMed ID: 22038096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fn14-Fc fusion protein regulates atherosclerosis in ApoE-/- mice and inhibits macrophage lipid uptake in vitro.
    Schapira K; Burkly LC; Zheng TS; Wu P; Groeneweg M; Rousch M; Kockx MM; Daemen MJ; Heeneman S
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2021-7. PubMed ID: 19762780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nebivolol treatment on atherosclerotic plaque components in apoE-knockout mice.
    Pyka-Fosciak G; Jawien J; Gajda M; Jasek E; Litwin JA
    J Physiol Pharmacol; 2013 Dec; 64(6):745-50. PubMed ID: 24388889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis.
    Leonarduzzi G; Gamba P; Gargiulo S; Biasi F; Poli G
    Free Radic Biol Med; 2012 Jan; 52(1):19-34. PubMed ID: 22037514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression.
    Liu G; Wang B; Zhang J; Jiang H; Liu F
    J Ethnopharmacol; 2009 Nov; 126(2):350-4. PubMed ID: 19703533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effect of anti-platelet therapies on atherosclerotic lesion formation assessed by phase-contrast X-ray CT imaging.
    Takeda M; Yamashita T; Shinohara M; Sasaki N; Tawa H; Nakajima K; Momose A; Hirata K
    Int J Cardiovasc Imaging; 2012 Jun; 28(5):1181-91. PubMed ID: 21688134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.